Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
University of Toronto · McGill University · +4 more institutions
Abstract
Anxiety and related disorders are among the most common mental disorders, with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are under-diagnosed and under-treated.
These guidelines were developed by Canadian experts in anxiety and related disorders through a consensus process. Data on the epidemiology, diagnosis, and treatment (psychological and pharmacological) were obtained through MEDLINE, PsycINFO, and manual searches (1980-2012). Treatment strategies were rated on strength of evidence, and a clinical recommendation for each intervention was made, based on global impression of efficacy, effectiveness, and side effects, using a modified version of the periodic health examination guidelines.
Citation impact
- FWCI
- 73.66
- Percentile
- 100%
- References
- 1,582
Authors
6Topics & keywords
- Anxiety
- Agoraphobia
- PsycINFO
- Panic disorder
- Psychiatry
- Specific phobia
- Generalized anxiety disorder
- Anxiety disorder
- Good health and well-being
Funding
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- PUPurdue University
- SSunovion
- NANational Alliance for Research on Schizophrenia and Depression
- VPValeant Pharmaceuticals International
- LLLes Laboratories Pierre Fabre
- CNCanadian Network for Mood and Anxiety Treatments
- CFCentre for Addiction and Mental Health Foundation
- PPPurdue Pharma
- SKSick Kids Foundation
- SServier
- HLH. Lundbeck A/S
- LCLundbeck Canada
- NINational Institutes of Health
- PCPfizer Canada
- ELEli Lilly Canada
- CICanadian Institutes of Health Research
- NINational Institute of Mental Health